Lv3
350 积分 2025-10-28 加入
Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway
8天前
已完结
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT‐737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment
8天前
已完结
Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment
8天前
已完结
The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
1个月前
已完结
[Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid Leukemia Cells]
1个月前
已完结
[Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid Leukemia Cells]
1个月前
已完结
Correction to: Thymine DNA glycosylase as a novel target for melanoma
1个月前
已完结
[Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid Leukemia Cells]
2个月前
已完结
GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes
2个月前
已完结
Emodin derivative E35 and its combination with autophagy inhibitor against acute myeloid leukemia cells in vitro and in vivo
2个月前
已完结
皖公网安备34019202002308
